BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1610859)

  • 1. Cyclosporine blood monitoring after heart transplantation: a prospective comparison of monoclonal and polyclonal radioimmunoassays.
    Bourge RC; Kirklin JK; Ketchum C; Naftel DC; Mason DA; Siegel AL; Scott JW; White-Williams C
    J Heart Lung Transplant; 1992; 11(3 Pt 1):522-9. PubMed ID: 1610859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and comparison of radioimmunoassay methods using monoclonal or polyclonal antibodies for the assay of cyclosporine in blood samples.
    Zucchelli GC; Clerico A; Pilo A; Masini S; Zoppi F; Bovati ML; Gazzetti P; Giovannini L; Bertelli AA
    Int J Tissue React; 1989; 11(6):315-20. PubMed ID: 2699881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the cyclosporine parent-compound-specific whole blood TDx assay.
    Pescovitz MD; Book BK; Pollard SG; Milgrom ML; Leapman SB; Filo RS
    Clin Transplant; 1992 Feb; 6(1):43-7. PubMed ID: 10147649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.
    Rodríguez E; Delucchi MA; Cano F; Valdebenito S; Castillo MC; Villegas R
    Transplant Proc; 2005 Oct; 37(8):3354-7. PubMed ID: 16298594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Zealand multicentre comparison of monoclonal (Sandimmun) versus polyclonal (cyclosporine-RIA) radioimmunoassays for cyclosporine blood monitoring.
    Cooke R; Wilson T; Tisch G; Rawlins J; Neale TJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1478-81. PubMed ID: 2652474
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine blood concentrations determined by different assay methods in heart transplant patients.
    Zylber-Katz E; Granit L
    Ther Drug Monit; 1989 Sep; 11(5):592-7. PubMed ID: 2815235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic cyclosporine monitoring: comparison of radioimmunoassay and high-performance liquid chromatography methods in organ transplant recipients.
    Hirvisalo EL; Kivistö KT; Neuvonen PJ
    Ther Drug Monit; 1990 Jul; 12(4):353-8. PubMed ID: 2396309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of the cyclosporine and metabolites whole blood TDx assay.
    Schroeder TJ; Pesce AJ; Hindenlang LL; Mauser PA; Ruckrigl DL; Weibel ML; Wadih G; First MR
    Ther Drug Monit; 1989; 11(4):480-2. PubMed ID: 2662481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary evaluation of a new chemiluminescence assay (Liaison Cyclosporine; DiaSorin Laboratories) allowing both C0 and C2 cyclosporine levels determination: comparison with RIA method.
    Olejnik Y; Elaerts S; Bonardet A; Chong G; Mourad G; Cristol JP; Dupuy AM
    Transplant Proc; 2005; 37(1):172-4. PubMed ID: 15808584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of simultaneous determination of cyclosporin blood levels using specific and nonspecific methods in liver transplantation].
    Piguet V; Mosimann F; Genton A; Appenzeller M; Munafo A; Bachmann C; Biollaz J
    Schweiz Med Wochenschr; 1992 Apr; 122(17):655-8. PubMed ID: 1589742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Neoral and Sandimmune cyclosporine for induction of immunosuppression after heart transplantation.
    Carrier M; White M; Pellerin M; Pelletier GB; Pelletier LC
    Can J Cardiol; 1997 May; 13(5):469-73. PubMed ID: 9179085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
    Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
    Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intragraft monitoring of rejection after prophylactic treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in heart transplant recipients.
    van Gelder T; Mulder AH; Balk AH; Mochtar B; Hesse CJ; Baan CC; Vaessen LM; Weimar W
    J Heart Lung Transplant; 1995; 14(2):346-50. PubMed ID: 7779855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, controlled trial of C0- Vs C2-guided therapeutic drug monitoring of cyclosporine in stable heart transplant patients.
    Mathias HC; Ozalp F; Will MB; Borland W; Payne C; Kerr M; Lockhart J; Murday AJ
    J Heart Lung Transplant; 2005 Dec; 24(12):2137-43. PubMed ID: 16364862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of cyclosporine monitoring in blood by specific and nonspecific radioimmunoassay methods in renal transplant patients with stable renal function and nephrotoxicity.
    Sabaté I; Castelao AM; Santos P; Bover J; Martínez JM; Ruiz R; González de la Presa B; Moliner R; Palencia T; Griñó JM
    Transplant Proc; 1995 Aug; 27(4):2254-5. PubMed ID: 7652796
    [No Abstract]   [Full Text] [Related]  

  • 17. Prediction of cyclosporine blood levels in heart transplantation patients using a pharmacokinetic model identified by evolutionary algorithms.
    Hoda MR; Grimm M; Laufer G
    J Heart Lung Transplant; 2005 Nov; 24(11):1855-62. PubMed ID: 16297792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The measurement of whole blood pre-treatment cyclosporine A: metabolite ratios predicts the onset of renal dysfunction in recipients of allogeneic stem cell transplantation.
    Stephens E; Bolderson I; Clark B; Kinsey S; Gooi HC; Cook G
    Ann Clin Biochem; 2006 Sep; 43(Pt 5):382-8. PubMed ID: 17022881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimum maintenance trough levels of cyclosporine in heart transplant recipients given corticosteroid-free regimen.
    Nohria A; Ehtisham J; Ramahi TM
    J Heart Lung Transplant; 1998 Sep; 17(9):849-53. PubMed ID: 9773855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of cyclosporine 2-hour post-dose levels in heart transplantation: improvement in clinical outcomes.
    Delgado DH; Rao V; Hamel J; Miriuka S; Cusimano RJ; Ross HJ
    J Heart Lung Transplant; 2005 Sep; 24(9):1343-6. PubMed ID: 16143255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.